Mode of death and outcomes of implantable cardioverter defibrillators in transthyretin amyloid cardiomyopathy

Mode of death and outcomes of implantable cardioverter defibrillators in transthyretin amyloid cardiomyopathy

Frédéric MOUQUET : Cardiologue CHU de Lille

https://pubmed.ncbi.nlm.nih.gov/34843821/